Human Papillomavirus, p16, and Epidermal Growth Factor Receptor Biomarkers and CT Perfusion Values in Head and Neck Squamous Cell Carcinoma

References

1. 1.↵
   1. Chung C,
   2. Gillison M

   . Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications. Clin Cancer Res 2009;15:6758–62

   Abstract/FREE Full Text
2. 2.↵
   1. D'Souza G,
   2. Kreimer A,
   3. Viscidi R,
   4. et al

   . Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356:1944–56

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Gillison ML,
   2. Koch WM,
   3. Capone RB,
   4. et al

   . Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92:709–20

   Abstract/FREE Full Text
4. 4.↵
   1. Yuen PW,
   2. Man M,
   3. Lam KY,
   4. et al

   . Clinicopathological significance of p16 gene expression in the surgical treatment of head and neck squamous cell carcinomas. J Clin Pathol 2002;55:58–60

   Abstract/FREE Full Text
5. 5.↵
   1. Nobori T,
   2. Miura K,
   3. Wu DJ,
   4. et al

   . Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994;368:753–56

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Kamb A,
   2. Gruis NA,
   3. Weaver-Feldhaus J,
   4. et al

   . A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994;264:436–40

   Abstract/FREE Full Text
7. 7.↵
   1. Wong TS,
   2. Man MW,
   3. Lam AK,
   4. et al

   . The study of p16 and p15 gene methylation in head and neck squamous cell carcinoma and their quantitative evaluation in plasma by real-time PCR. Eur J Cancer 2003;39:1881–87

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Fischer CA,
   2. Kampmann M,
   3. Zlobec I,
   4. et al

   . p16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters. Ann Oncol 2010;21:1961–66

   Abstract/FREE Full Text
9. 9.↵
   1. Santini J,
   2. Formento JL,
   3. Francoual M,
   4. et al

   . Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas. Head Neck 1991;13:132–39

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Kalyankrishna S,
    2. Grandis J

    . Epidermal growth factor receptor biology in head and neck cancer. J Clin Oncol 2006;24:2666–72

    Abstract/FREE Full Text
11. 11.↵
    1. Fei J,
    2. Hong A,
    3. Dobbins T,
    4. et al

    . Prognostic significance of vascular endothelial growth factor in squamous cell carcinomas of the tonsil in relation to human papillomavirus status and epidermal growth factor receptor. Ann Surg Oncol 2009;16:2908–17

    CrossRefPubMed
12. 12.↵
    1. Zima A,
    2. Carlos R,
    3. Gandhi D,
    4. et al

    . Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy? AJNR Am J Neuroradiol 2007;28:328–34

    Abstract/FREE Full Text
13. 13.↵
    1. Surlan-Popovic K,
    2. Bisdas S,
    3. Rumboldt Z,
    4. et al

    . Changes in perfusion CT of advanced squamous cell carcinoma of the head and neck treated during the course of concomitant chemoradiotherapy. AJNR Am J Neuroradiol 2010;31:570–75

    Abstract/FREE Full Text
14. 14.↵
    1. Tang AL,
    2. Hauff SJ,
    3. Owen JH,
    4. et al

    . UM-SCC-104: a new human papillomavirus-16 positive-cancer stem cell-containing head and neck squamous cell carcinoma cell line. Head Neck 2012;34:1480–91

    CrossRefPubMed
15. 15.↵
    1. Ash L,
    2. Teknos T,
    3. Gandhi D,
    4. et al

    . Head and neck squamous cell carcinoma: CT perfusion can help noninvasively predict intratumoral microvessel density. Radiology 2009;251:422–28

    CrossRefPubMed
16. 16.↵
    1. Bisdas S,
    2. Baghi M,
    3. Smolarz A,
    4. et al

    . Quantitative measurements of perfusion and permeability of oropharyngeal and oral cavity cancer, recurrent disease, and associated lymph nodes using first-pass contrast-enhanced computed tomography studies. Invest Radiol 2007;42:172–79

    CrossRefPubMed
17. 17.↵
    1. Kumar B,
    2. Cordell K,
    3. Lee J,
    4. et al

    . EGFR, p16, HPV titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol 2008;26:3128–37

    Abstract/FREE Full Text
18. 18.↵
    1. Pivot X,
    2. Magn N,
    3. Guardiola E,
    4. et al

    . Prognostic impact of the epidermal growth factor receptor levels for patients with larynx and hypopharynx cancer. Oral Oncol 2005;41:320–27

    CrossRefPubMed
19. 19.↵
    1. Bisdas S,
    2. Nguyen S,
    3. Anand S,
    4. et al

    . Outcome prediction after surgery and chemoradiation of squamous cell carcinoma in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume. Int J Radiat Oncol Biol Phys 2009;73:1313–18

    PubMed